The University of Oxford, which is partnering with large-cap pharma AstraZeneca plc (NYSE: AZN) to develop a vaccine for SARS-CoV-2, could lead the pack in advancing its vaccine candidate to the next stage.The university is one of the eight companies and institutions that have advanced their candidates to human testing, according to the latest World Health Organization statistics.Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.Phase 1 Results In Mid-June About 1,000 people have been vaccinated in the first phase of the vaccine program, which is going as planned and without safety scares, Prof. John Bell, regius professor of medicine at the Oxford University, reportedly told BBC Radio 4's Today program.Results of the Phase 1/2 trial that is underway could be available by mid-June, Bell said. "We also want to make sure that the rest of the world...
Is the market’s rally reaching a standstill? Doubts about valuations and Federal Reserve Chair Jerome Powell’s warning regarding economic risks weighed on stocks, with the S&P 500 slipping for the third day in a row today. Yet, the index still remains over 25% higher than its March 23 low.Investors are uncertain just where the stock market is headed. Essentially, there are two competing opinions right now. One says that we’re just in a bear market rally, and that the worst is yet to come. The other thesis states that the current rally is real, and will mature into a new bull cycle as the economy restarts in the second half.Nonetheless, investors are constantly looking for stocks that will hold up regardless of economic uncertainty. A good starting point is recent analyst activity. With this in mind, we used TipRanks' database to pinpoint 3 trending stocks which were reassessed by those in...
